Please assess the completion status of the following clinical trial:

Trial Title: Comparative Impact of Protocolized Management, Intensive Rehabilitation Versus Long-term Classic Rehabilitation of Dyslexic Children.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Children from 8 to 12 years old,~* Living in and around 50 kilometers from Besançon.~* Diagnosis of dyslexia according to the DSM-V or CIM-10 requirements.~* Consent form signed by the parental authority and the child,~* Affiliation to a social security system.~Exclusion Criteria:~* Mother's medical history of pregnancy or delivery complications,~* Patients's medical history of neurological infectious, vascular or tumoral events,~* Patient's medical history of intellectual deficiency,~* Patients's medical history of visual or hearing disorders,~* Patient's medical history of psychiatric disorders (especially diagnosis of Attention Deficit / Hyperactivity Disorders (AD/HD)),~* legal incapacity,~* limited cooperation suspected by the investigator.

- Gender: ALL
- Minimum Age: 8 Years
- Maximum Age: 12 Years
- Healthy Volunteers: f

Study Arms:
- intensive arm (Type: EXPERIMENTAL): The children included in this arm will receive two weeks of daily care during which two daily speech therapy sessions of one hour each will be performed. This will be done between M2 and M4 of inclusion in order to avoid potential measurement bias. These sessions will be carried out by a state-qualified speech therapist employed at the CRRF of Bregille. They will guide the intensive rehabilitation of dyslexic children by focusing the exercises on their main difficulties.
- classic arm or gold standard (Type: ACTIVE_COMPARATOR): The speech therapy session will be provided only by private practitioners, with a weekly consultation of 30 minutes. The private speech therapist who initially referred the patient for inclusion in the research protocol will be responsible for his or her classic rehabilitation. The therapy will continue during the 6 months of research.

Based on this trial design, predict the completion outcome and termination type (if applicable).